EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 530 participants.
Also called NCT05151172
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 530 participants
- Sponsor
- Registry
-
NCT05151172
-
- Other papers using this trial's data
- Thrombectomy for Acute Stroke Due to Medium Vessel Occlusion Across Perfusion Mismatch Profiles: A Post Hoc Analysis of the ESCAPE-MeVO Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT05151172. Randomized; single masking; primary purpose treatment. Start 2022-04-15 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
- Acronym
- ESCAPE-MeVO
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- endovascular thrombectomy (EVT)
- Intervention (Other)
- Standarad medical care
- Lead sponsor
- Dr. Michael D Hill
- Collaborator
- University of Calgary
Record details
- Record id
cardio:ct-nct05151172- Content hash
3ef36c77ea7aa7e26a8425f58f6fbe1de9344222f9ff6721e2e6a33898d3f989